Dollar and Under Sleeper Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Dollar and Under Sleeper Stocks

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: one_less who wrote (5514)	3/16/1998 10:53:00 AM
From: Don Lachot	Read Replies (2) of 8835

ADOT news: ALBUQUERQUE, N.M.--(BUSINESS WIRE)--March 16, 1998--Advanced Optics Electronics, Inc. (OTC BB: ADOT), today announced major developments from Biomoda, Inc., a medical technology company in which Advanced Optics holds a significant minority interest. Biomoda, Inc. is in final negotiations with a leading cytopathology lab to form a joint venture and begin testing of Biomoda's proprietary sputum diagnostic technology. Biomoda, Inc. is anticipating its effective cancer testing/treatment program will enter the public market the end of the second quarter of 1999. Biomoda will initially pursue market share in the $3 billion lung cancer market and later in the $750 million inflammatory bowel disease market. Biomoda's application of porphyrin compounds to cancer therapies is an area of intense pharmaceutical research and development. Biomoda currently stands alone as the only company with a patented early detection test (able to detect lung cancer at least six years earlier than any other test) and an integrated treatment program. Biomoda's treatment program is effective on both surface cancers and internal cancers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next